The answer to noninvasive biomarker development in lung cancer
- Artificial intelligence
- 28/11/2017
During an overcrowded exhilarating session on Monday 27th November at the RSNA 2017 Congress in Chicago, Dr. Hugo Aerts, from Harvard University
READ MORE